Politics & Government

Blood Center Opponents Invoke Rare Clause In Bid To Kill Project

Here's how to watch Tuesday's vote deciding the fate of the controversial rezoning, where opponents plan a last-ditch bid to derail it.

Left: a rendering of the newly-shortened New York Blood Center tower proposal on East 67th Street. Right: City Councilmember Ben Kallos speaks at a May rally against the rezoning.
Left: a rendering of the newly-shortened New York Blood Center tower proposal on East 67th Street. Right: City Councilmember Ben Kallos speaks at a May rally against the rezoning. (Longfellow Real Estate Partners; Nick Garber/Patch)

Update, 9:37 a.m. Tuesday: the City Council subcommittee vote on the Blood Center rezoning has been postponed until Wednesday.


UPPER EAST SIDE, NY — As the New York Blood Center's divisive rezoning on the Upper East Side faces a deciding vote in the City Council, opponents have launched a last-ditch effort to derail it.

A Council committee is expected to vote Tuesday morning whether to approve the Blood Center's bid to upzone a stretch of East 67th Street in order to build a 276-foot research tower. The proposal has stoked intense opposition in the neighborhood for nearly a year, including from local member Ben Kallos, who has railed against the tower for its impact on an adjacent park and school.

Find out what's happening in Upper East Sidefor free with the latest updates from Patch.

But Kallos's wishes could be thwarted by his own Council colleagues — reports emerged that they may vote to approve it anyway and thus upend the decades-old practice of "member deference" that would respect his wishes.

Still, Kallos asserted Monday that opponents of the project have a procedural end run of their own: community members filed a formal protest with the city that takes advantage of an obscure City Charter provision to raise the vote threshold on rezonings. The objections filed would raise the required vote from the typical majority to three-quarters of Council members — a level that Kallos believes will doom the project.

Find out what's happening in Upper East Sidefor free with the latest updates from Patch.

"I don’t believe that the City Council can get 39 people to vote against member deference," Kallos told Patch. "Especially with a developer that’s refused to even meet with the local Council member."

The Blood Center is seeking to knock down its aging, three-story brick headquarters on East 67th Street (left) and replace it with the research tower (right), which would require rezoning the block to allow for taller, denser construction. (Google Maps/Longfellow Real Estate Partners)

The objections were filed by the board of 301 East 66th St., one of two adjacent buildings that is included in the Blood Center's plans as part of what critics say is a bid by developers to broaden the rezoning and avoid charges of an illegal "spot zoning."

The latest setback for residents seeking to kill the zoning came hours earlier on Monday, when Land Use Committee Chair Rafael Salamanca Jr. told POLITICO that he would vote to approve it.

"It’s hard to tell a nonprofit that saves lives, to say no to them, when they’re trying to increase their capacity and their research for New Yorkers," Salamanca told the publication. "It’s hard to tell them no when your only argument is you’re concerned about the shadows in your community."

The co-op board of 301 East 66th St., adjacent to the Blood Center, has filed a formal protest against the rezoning in an effort to raise its vote threshold in the Council. (Google Maps)

Council leaders had given no indication that Monday's vote would deviate from the typical majority threshold, but Kallos said he was confident that the objections would have their desired effect.

Tuesday's hearing by the Council's Subcommittee on Zoning and Franchises will begin at 10 a.m., and will be streamed at council.nyc.gov/livestream.

Patch writer Matt Troutman contributed reporting.

More Blood Center coverage:

Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.